Additionally, while CDC20, COL1A2 and S100A10 possess recognized pro-oncogenic activities, the precise roles of B4GALNT4 and NUAK1 in prostate cancer warrant elucidation. This evidence concerns the gene COL1A2 and Familial prostate cancer.